Medical Oxygen Concentrators Market Size, Share, and Trends

Medical Oxygen Concentrators Market (By Technology: Pulse Dose, Continuous Flow, and Others; By Product: Fixed and Portable; By Application: Non-home Care and Home Care) - Global Industry Analysis, Market Size, Share, Growth, Trends, Regional Outlook and Forecast 2021 - 2030

  • Last Updated : January 2021
  • Report Code : 1198
  • Category : Healthcare

The global medical oxygen concentrators market size was estimated at USD 3.23 billion in 2020 and is expected to reach USD 4.99 billion by the end of 2030 growing at a compound annual growth rate (CAGR) of 12.8% during the forecast period 2021 to 2030.

Medical Oxygen Concentrators Market Size 2017 to 2030

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Key Takeaways

  • North America led the global market with the highest market share in 2021.
  • By Technology, the continuous flow segment had the biggest market share in 2021.
  • By Product, the portable medical oxygen segment dominated the global market in 2021.
  • By Application, the home care segment has held the largest revenue share in 2021.

Major Trends in the Medical Oxygen Concentrators Industry:

The oxygen therapy sector is evolving speedily with the incorporation of new technologies in the currently available products. These new devices have rectified some problems that were responsible for the side-effects related with the oxygen flow. Lately, new devices have been designed that automatically regulate oxygen stream rates to the requirements of each patient, for maintaining constant oxygen-saturation levels. Such closed-loop arrangements can potentially decrease medical error, reduce morbidity and mortality, and decrease care costs. The advance of continuous-flow technology has carried out major improvements in the working of medical oxygen concentrators. Technologies such as pulse dose technology are also expected to open up new avenues for the creators of oxygen concentrators. Convenience like high mobility, better comfort, improved technologies, and increased efficiencies presented by the technology will enhance its demand in the near future.

The portable oxygen concentrators have undergone major technical improvements and these modern oxygen concentrators are evolving continuously. The ease offered by these little, quitter, and light concentrators is anticipated to boost the progress of oxygen concentrators. These aspects along with high expenditure by major companies in research and development, growing per capita healthcare spending in developing nations, and combination of latest software with the advanced oxygen concentrators to increase efficacy of products is expected to offer new prospects in the worldwide medical oxygen concentrators market.

Medical Oxygen Concentrators Market Scope

Report Highlights Details
Growth Rate from 2021 to 2030 CAGR of 12.8%
Market Size in 2020 USD 3.23 Billion
Market Size by 2030 USD 4.99 Billion
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Technology, Product, Application
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Teijen, DeVilbiss Healthcare, AirSep, Inogen, Nidek Medical, Invacare, O2 Concepts, Inova Labs, Covidien, Philips Respironics

 

Crucial factors accountable for market growth are:

  • Increasing prevalence of respiratory ailments
  • Growing geriatric population
  • High investment in research and development
  • Increasing focus on home healthcare
  • Increasing per capita healthcare expenditure
  • Growing incidence of novel viral diseases
  • Technological advancements
  • Improving reimbursement scenario in developing regions

COVID-19 Impact on Global Medical Oxygen Concentrators Market

Increasing number of COVID-19 cases is expected to drive the demand for medical oxygen globally. The unparalleled high requirement for medical oxygen has led to in high demand for medical oxygen concentrators. As medical oxygen concentrators are employed in the home settings or hospitals to make oxygen for the patients, they have an important application in the treatment of COVID-19. A robust industrial base and a large number of established manufacturers of medical oxygen concentrators in the U.S. are expected to contribute to the growth of medical oxygen concentrators. The business for medical devices is commanded by imports as most locally manufactured devices are exported to other regions. With an amplified demand for imported devices, the governing system along with the healthcare business is more open to advanced and novel technologies that have increased imports of medical equipments in emerging countries such as India. Nevertheless, for the year 2020, imports and exports have been radically affected due to the closed border of major economies in order to avert the spread of novel coronavirus.

Future of Medical Oxygen Concentrators

The companies operating in the medical oxygen concentrators market are significantly increasing their production capacities and education efforts to fulfil the rising need of these concentrators. For instance, on 4 April 2019 Inogen, Inc. which is one of the major players of the market had recently announced the launch of its Inogen One G5, a portable medical oxygen concentrator. The device is now accessible for sale through the local direct-to-consumer sales network company for individuals suffering from respiratory ailments.

Technology Insights

Continuous Flow Reported Foremost Market Stake in 2021

Continuous Flow segment displayed the major share in the worldwide medical oxygen concentrators market, by technology, in 2019. The improvements carried out in the technology in order to make the equipment’s more efficient is the major reason for high market share of continuous flow technology. The factors such as multiple benefits over other technologies are expected to retain the dominance of continuous flow technology in the near future.

The pulse flow technology is projected grow at the highest CAGR through the forecast time-frame mainly due totechnological advancements.

Product Insights

Portable Medical Oxygen Concentrators Dominated the Market Revenue

Portable oxygen concentrators are gaining immense popularity due to their ease of use and affordability. Portable medical oxygen concentrators can be used in the treatment of multiple respiratory ailments such as asthma and COPD.Thus, high incidence of respiratory ailments is expected to boost the demand for portable oxygen concentrators in the forecast time-frame.

Application Insights

Home Care Will Dominate the Application Segment of Medical Oxygen Concentrators Market Revenue

Home care services offer the convenience of carrying out treatment for chronic disorders at the home of the patients. The preference for home care is on the rise in developed regions majorly due to high geriatric population. Furthermore,the use of portable oxygen concentrators is extremely convenient for the elderly patients. These factors contribute to the growth of home care services segment.

Regional Insights

North America is Estimated to be the Largest Market for Medical Oxygen Concentrators

The research study covers key prospects and trends of medical oxygen concentrators products throughout different regions including Europe, North America, Asia-Pacific, Middle East and Africa, and Latin America. Regionally, medical oxygen concentrators market is dominated by North America due to presence of skilled researchers and high prevalence of chronic respiratory ailments. Europe accounted for the second highest share majorly due to encouraging reimbursement scenario and high geriatric population. On the other hand, Asia-Pacific is anticipated to witness the rapid growth rate, on account of increasing investment by major manufacturers, high tobacco usage for smoking, and growing per-capita healthcare expenditure.

Medical Oxygen Concentrators Market Players

The companies focusing on research and development are expected to lead the global medical oxygen concentrators market. Leading competitors contending in global medical oxygen concentrators market are as follows:

  • Teijen
  • DeVilbiss Healthcare
  • AirSep
  • Inogen
  • Nidek Medical
  • Invacare
  • O2 Concepts
  • Inova Labs
  • Covidien
  • Philips Respironics

In order to better recognize the current status of medical oxygen concentrators, and policies adopted by the foremost countries, Precedence Research predicted the future evolution of the medical oxygen concentrators market. This research study bids qualitative and quantitative insights on medical oxygen concentrators market and assessment of market size and growth trend for potential market segments.

Key Market Developments:

  • On 4 April 2019 Inogen, Inc. recently declared the launch of its Inogen One G5 portable oxygen concentrator.
  • In January 2018, ResMed introduced its branded portable oxygen concentrator, Mobi.

Major Market Segments Covered:

By Technology

  • Pulse Dose
  • Continuous Flow
  • Others

By Product

  • Fixed
  • Portable

By Application

  • Non-home Care
  • Home Care

By Geography

  • North America
      • U.S.
      • Canada
  • Europe
      • Germany
      • France
      • United Kingdom
      • Rest of Europe
  • Asia Pacific
      • China
      • Japan
      • India
      • Southeast Asia
      • Rest of Asia Pacific
  • Latin America
      • Brazil
      • Rest of Latin America
  • Middle East & Africa (MEA)
      • GCC
      • North Africa
      • South Africa
      • Rest of Middle East & Africa

Frequently Asked Questions

The global medical oxygen concentrators market was valued at USD 3.23 billion in 2020 and expected to reach USD 4.99 billion by the end of 2030.

The global medical oxygen concentrators market is representing impressive compound annual growth rate (CAGR) of 12.8% during the forecast period 2021 to 2030.

Factors such as increasing prevalence of respiratory ailments, growing geriatric population, high investment in research and development, increasing focus on home healthcare, increasing per capita healthcare expenditure, growing incidence of novel viral diseases, technological advancements, and improving reimbursement scenario in developing regions are driving the growth of medical oxygen concentrators market.

North America dominated the global market with a market share of more than 35%.

Asia Pacific is estimated to advance at the maximum CAGR of around 6.1% in the forecast period due to high incidence of respiratory ailments.

The portable medical oxygen concentrators accounted for the largest revenue in the product segment with more than 58% share in 2020.

The major companies operating in the worldwide medical oxygen concentrators market are Teijen, DeVilbiss Healthcare, AirSep, Inogen, Nidek Medical, Invacare, O2 Concepts, Inova Labs, Covidien, and Philips Respironics among others.

An oxygen concentrator is an equipment used to dispense oxygen for patients with a low oxygen level in their blood.

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Medical Oxygen Concentrators Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Medical Oxygen Concentrators Market

5.1. Covid-19: Medical Oxygen Concentrators Industry Impact
5.2. Medical Oxygen Concentrators Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Medical Oxygen Concentrators Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Medical Oxygen Concentrators Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Medical Oxygen Concentrators Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing prevalence of respiratory ailments
6.1.1.2. Growing geriatric population
6.1.2. Market Restraints
6.1.2.1. High cost
6.1.3. Market Opportunities
6.1.3.1. Technological advancements
6.1.3.2. Improving reimbursement scenario in developing regions

Chapter 7. Global Medical Oxygen Concentrators Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Medical Oxygen Concentrators Market Revenue by Market Players (2016 -2019)
7.1.1.2. Medical Oxygen Concentrators Market Revenue Market Share by Market Players (2016 -2019)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Technology Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Medical Oxygen Concentrators Market, By Technology

8.1. Medical Oxygen Concentrators Market, by Technology, 2017-2030
8.1.1. Pulse Dose
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Continuous Flow
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Medical Oxygen Concentrators Market, By Product

9.1. Medical Oxygen Concentrators Market, by Product, 2017-2030
9.1.1. Fixed
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Portable
9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Medical Oxygen Concentrators Market, By Application

10.1. Medical Oxygen Concentrators Market, by Application, 2017-2030
10.1.1. Non-home Care
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Home Care
10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Medical Oxygen Concentrators Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Technology(2017-2030)
11.1.2. Market Revenue Forecast by Product(2017-2030)
11.1.3. Market Revenue Forecast by Application (2017-2030)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2017-2030)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2017-2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Technology (2017-2030)
11.2.2. Market Revenue Forecast by Product (2017-2030)
11.2.3. Market Revenue Forecast by Application (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2017-2030)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2017-2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Technology (2017-2030)
11.3.2. Market Revenue Forecast by Product (2017-2030)
11.3.3. Market Revenue Forecast by Application (2017-2030)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2017-2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Technology (2017-2030)
11.4.2. Market Revenue Forecast by Product (2017-2030)
11.4.3. Market Revenue Forecast by Application (2017-2030)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2017-2030)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2017-2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Technology (2017-2030)
11.5.2. Market Revenue Forecast by Product (2017-2030)
11.5.3. Market Revenue Forecast by Application (2017-2030)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2017-2030)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2017-2030)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2017-2030)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2017-2030)

Chapter 12. Company Profiles

12.1. Teijen
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin (2015-2020)
12.1.4. Recent Developments and Strategies
12.2. DeVilbiss Healthcare
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin (2015-2020)
12.2.4. Recent Developments and Strategies
12.3. AirSep
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin (2015-2020)
12.3.4. Recent Developments and Strategies
12.4. Inogen
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin (2015-2020)
12.4.4. Recent Developments and Strategies
12.5. Nidek Medical
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin (2015-2020)
12.5.4. Recent Developments and Strategies
12.6. Invacare
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin (2015-2020)
12.6.4. Recent Developments and Strategies
12.7. O2 Concepts
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin (2015-2020)
12.7.4. Recent Developments and Strategies
12.8. Inova Labs
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin (2015-2020)
12.8.4. Recent Developments and Strategies
12.9. Covidien
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin (2015-2020)
12.9.4. Recent Developments and Strategies
12.10. Philips Respironics
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin (2015-2020)
12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client